2,981 results found

Senior associate Molly Reynolds, associate Caitlin Morin, and articling student Amir Eftekharpour have co-authored "Ontario Court of Appeal Clarifies Privacy Obligations for Utilities" for the Energy Regulation Quarterly.

Powering the Future: SMRs, Nuclear Fuel, and Decarbonizing the Mining Sector was cohosted in partnership with the Nuclear Energy Agency (NEA/OECD) and supported through sponsorship by Centrus Energy, NexGen Energy...

In his first week as Prime Minister, Mark Carney expressed his vision for Canada to be the "world's leading energy superpower in both clean and conventional energy."

On June 2, 2008, the premiers of Ontario and Quebec signed a Memorandum of Understanding (MOU) committing the two provinces to establish a joint greenhouse gas (GHG) emissions cap-and-trade regime.

GP stakes transactions—namely, minority investments by third-party investors in a private asset manager—were once viewed primarily as a founder liquidity tool. The market, however, has evolved well beyond that original story, with these transactions increasingly framed as strategic partnerships rather than mere financing events.

On July 29, the Financial Consumer Agency of Canada (the FCAC) published final versions of three guidance documents to assist with the implementation of new disclosure requirements set out in the April 2015 update...

On September 19, 2005, Minister of Finance Ralph Goodale announced that he has requested the Minister of National Revenue to postpone, with immediate effect, providing advance tax rulings respecting flow-through entities (FTEs), such as income trusts.

The TSX expects most securityholder rights plans to have a triggering threshold of 20%, consistent with takeover bid requirements under Canadian securities legislation.

The Ontario Budget Measures Act, 2009 includes some significant amendments to the Securities Act (Ontario).

After multiple delays in the implementation of amendments to Canada's Patented Medicines Regulations, the Minister of Health announced that the new basket of comparator countries and...

The Government of Canada published a Consultation Paper proposing regulatory changes to a class of products identified as "self-care products," namely cosmetics, natural health products and non-prescription drugs.

Last week, the Government of Canada signed an agreement to amend the United States-Mexico-Canada Agreement (USMCA).

The Medical Devices Bureau of Health Canada (the Bureau) expects that all Class I Medical Device software marketed in Canada will be compliant with the Medical Devices Regulations (the Regulations) by February 1, 2011, and all Class II Medical Device software will be compliant by September 1, 2011.

Canada is subject to a patchwork of laws and policies relating to the pricing and reimbursement of drug products.

Litigation associate Craig Gilchrist spoke with the OBA to discuss mental health from a working lawyer's perspective.

Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities.

The regulation of private label drug products remains in flux with the recent decision of the Ontario Superior Court of Justice (Divisional Court) and potential appeal of that decision.

The Discussion Paper hints that the PMPRB may propose a number of reforms to the Guidelines which would likely lower the maximum allowable prices of many patented medicines at and after introduction.